Safety Study on AdCD40L Gene Therapy for Bladder Cancer

Summary

The study objective is to evaluate the feasibility of three instillations of immunostimulating gene therapy (AdCD40L) in patients with urinary bladder cancer. Tolerance, toxicity and immunological parameters will be evaluated during and post treatment.

Timeline

Start

2006-11

Primary completion

2009-10

Completion

2009-10

Drugs

Indications